Literature DB >> 27569393

Salvianolic acid B stimulates osteogenesis in dexamethasone-treated zebrafish larvae.

Shi-Ying Luo1,2, Jing-Feng Chen2, Zhi-Guo Zhong3, Xiao-Hua Lv2, Ya-Jun Yang2, Jing-Jing Zhang3, Liao Cui1,2.   

Abstract

AIM: Our previous studies show that salvianolic acid B (Sal B) promotes osteoblast differentiation and matrix mineralization. In this study, we evaluated the protective effects of Sal B on the osteogenesis in dexamethasone (Dex)-treated larval zebrafish, and elucidated the underlying mechanisms.
METHODS: At 3 d post fertilization, wild-type AB zebrafish larvae or bone transgenic tg (sp7:egfp) zebrafish larvae were exposed to Sal B, Dex, or a mixture of Dex+Sal B for 6 d. Bone mineralization in AB strain larval zebrafish was assessed with alizarin red staining, and osteoblast differentiation in tg (sp7:egfp) larval zebrafish was examined with fluorescence scanning. The expression of osteoblast-specific genes in the larvae was detected using qRT-PCR assay. The levels of oxidative stress markers (ROS and MDA) in the larvae were also measured.
RESULTS: Exposure to Dex (5-20 μmol/L) dose-dependently decreased the bone mineralization area and integral optical density (IOD) in wild-type AB zebrafish larvae and the osteoblast fluorescence area and IOD in tg (sp7:egfp) zebrafish larvae. Exposure to Dex (10 μmol/L) significantly reduced the expression of osteoblast-specific genes, including runx2a, osteocalcin (OC), alkaline phosphatase (ALP) and osterix (sp7), and increased the accumulation of ROS and MDA in the larvae. Co-exposure to Sal B (0.2-2 μmol/L) dose-dependently increased the bone mineralization area and IOD in AB zebafish larvae and osteoblast fluorescence in tg (sp7:egfp) zebrafish larvae. Co-exposure to Sal B (2 μmol/L) significantly attenuated deleterious alterations in bony tissue and oxidative stress in both Dex-treated AB zebafish larvae and tg (sp7:egfp) zebrafish larvae.
CONCLUSION: Sal B stimulates bone formation and rescues GC-caused inhibition on osteogenesis in larval zebrafish by counteracting oxidative stress and increasing the expression of osteoblast-specific genes. Thus, Sal B may have protective effects on bone loss trigged by GC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27569393      PMCID: PMC5057235          DOI: 10.1038/aps.2016.62

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  38 in total

Review 1.  Glucocorticoid-Induced Osteoporosis.

Authors:  Baruch Frenkel; Wendy White; Jan Tuckermann
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 2.  Zebrafish embryos and larvae: a new generation of disease models and drug screens.

Authors:  Shaukat Ali; Danielle L Champagne; Herman P Spaink; Michael K Richardson
Journal:  Birth Defects Res C Embryo Today       Date:  2011-06

3.  Features of mono- and multinucleated bone resorbing cells of the zebrafish Danio rerio and their contribution to skeletal development, remodeling, and growth.

Authors:  P E Witten; A Hansen; B K Hall
Journal:  J Morphol       Date:  2001-12       Impact factor: 1.804

4.  High-throughput in vivo screening for bone anabolic compounds with zebrafish.

Authors:  Angeleen Fleming; Masahiko Sato; Paul Goldsmith
Journal:  J Biomol Screen       Date:  2005-10-18

Review 5.  Zebrafish as a pharmacological tool: the how, why and when.

Authors:  Paul Goldsmith
Journal:  Curr Opin Pharmacol       Date:  2004-10       Impact factor: 5.547

6.  Effect of glucocorticoid-induced oxidative stress on the expression of Cbfa1.

Authors:  Yan-Ling Feng; Xu-Lei Tang
Journal:  Chem Biol Interact       Date:  2013-11-15       Impact factor: 5.192

7.  Osteogenic effects of D+beta-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats.

Authors:  Liao Cui; Yu-Yu Liu; Tie Wu; Chun-Mei Ai; Huai-Qing Chen
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

Review 8.  Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery.

Authors:  T P Barros; W K Alderton; H M Reynolds; A G Roach; S Berghmans
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

9.  Osteoclast-like Cells in Early Zebrafish Embryos.

Authors:  Faiza Sharif; Merijn A G de Bakker; Michael K Richardson
Journal:  Cell J       Date:  2014-05-25       Impact factor: 2.479

10.  Antioxidant activity and components of a traditional Chinese medicine formula consisting of Crataegus pinnatifida and Salvia miltiorrhiza.

Authors:  Cheng-Yu Chen; Hua Li; Ya-Nan Yuan; Hui-Qing Dai; Bin Yang
Journal:  BMC Complement Altern Med       Date:  2013-05-10       Impact factor: 3.659

View more
  4 in total

1.  Screening in larval zebrafish reveals tissue-specific distribution of fifteen fluorescent compounds.

Authors:  Yuxiao Yao; Shaoyang Sun; Fei Fei; Jingjing Wang; Youhua Wang; Ranran Zhang; Jing Wu; Lian Liu; Xiuyun Liu; Zhaomeng Cui; Qiang Li; Min Yu; Yongjun Dang; Xu Wang
Journal:  Dis Model Mech       Date:  2017-07-28       Impact factor: 5.758

2.  Predicting and Exploring the Mechanisms of Erzhi Pill in Prevention and Treatment of Osteoporosis Based on Network Pharmacology and Zebrafish Experiments.

Authors:  Zhiguo Zhong; Yuyun Li; Yan Chen; Wen Chen; Siyan Li; Xiaohua Lv; Shiying Luo
Journal:  Drug Des Devel Ther       Date:  2021-02-24       Impact factor: 4.162

Review 3.  Fish Models of Induced Osteoporosis.

Authors:  Joana T Rosa; Vincent Laizé; Paulo J Gavaia; M Leonor Cancela
Journal:  Front Cell Dev Biol       Date:  2021-06-10

4.  Dexamethasone Down-regulates Osteocalcin in Bone Cells through Leptin Pathway.

Authors:  Shu-Mei Chen; Yi-Jen Peng; Chih-Chien Wang; Sui-Lung Su; Donald M Salter; Herng-Sheng Lee
Journal:  Int J Med Sci       Date:  2018-03-08       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.